JW

Jiabing Wang

Merck: 15 patents #708 of 9,382Top 8%
BC Betta Pharmaceuticals Co.: 7 patents #5 of 37Top 15%
AA Astrazeneca Ab: 3 patents #459 of 1,971Top 25%
MK Msd K.K.: 2 patents #42 of 111Top 40%
HE Hewlett Packard Enterprise: 1 patents #2,081 of 4,473Top 50%
DC Dizal (Jiangsu) Pharmaceutical Co.: 1 patents #32 of 36Top 90%
WARF: 1 patents #1,912 of 4,123Top 50%
Overall (All Time): #120,211 of 4,157,543Top 3%
30
Patents All Time

Issued Patents All Time

Showing 25 most recent of 30 patents

Patent #TitleCo-InventorsDate
12187713 Immunomodulators, compositions and methods thereof Yiqian Wang, Yao ZHANG, Bang FU, Lieming DING 2025-01-07
12043622 Crystal form of compound for inhibiting the activity of CDK4/6 and use thereof Yiqian Wang, Chunhui Zhang, Lieming DING 2024-07-23
11845762 Compound functioning as bromodomain protein inhibitor, and composition Yan Xu, Xiaofeng Xu, Lieming DING 2023-12-19
11466013 ERK inhibitor and use thereof Hao Wu, Wei Gu, Xiaojing Tang, Wei Wang, Bo ZHAN +8 more 2022-10-11
11466034 Compound functioning as bromodomain protein inhibitor, and composition Yan Xu, Xiaofeng Xu, Lieming DING 2022-10-11
11447492 ERBB receptor inhibitors Zhengtao LI, Wei Zhong, Qingbei Zeng, Honchung Tsui, Zhenfan Yang +1 more 2022-09-20
11365196 FGFR inhibitor and application thereof Xiaofeng Xu, Lieming DING, Xiangyong LIU 2022-06-21
11053238 Benzimidazole derivatives, preparation methods and uses thereof Yiqian Wang, Lieming DING 2021-07-06
10822334 ErbB receptor inhibitors Zhengtao LI, Wei Zhong, Qingbei Zeng, Honchung Tsui, Zhenfan Yang +1 more 2020-11-03
10484272 Packet forwarding in RPR network Wenjun Du, Zhixin Xiong 2019-11-19
9718806 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor David Yunzhi Li, Zhenfan Yang, Qingbei Zeng, Xiaolin Zhang 2017-08-01
9375432 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor David Yunzhi Li, Zhenfan Yang, Qingbei Zeng, Xiaolin Zhang 2016-06-28
9066979 Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor David Yunzhi Li, Zhenfan Yang, Qingbei Zeng, Xiaolin Zhang 2015-06-30
8691825 Inhibitors of AKT activity Qi Chen, Mingxiang Cui, Bin Hu, Shuangxi Hu, Zhifa Pu +6 more 2014-04-08
8536193 Inhibitors of AKT activity Hidetomo Furuyama, Yasuhiro Goto, Nobuhiko Kawanishi, Mark E. Layton, Takashi Mita +5 more 2013-09-17
8207169 Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D Hidetomo Furuyama, Yasuhiro Goto, Nobuhiko Kawanishi, Mark E. Layton, Takashi Mita +6 more 2012-06-26
8008317 Inhibitors of akt activtiy Donna J. Armstrong, Essa Hu, Michael J. Kelly, III, Mark E. Layton, Yiwei Li +4 more 2011-08-30
7763659 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell +2 more 2010-07-27
7629367 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell +2 more 2009-12-08
7625919 4-azasteroid derivatives as androgen receptor modulators Carol A. McVean 2009-12-01
7482359 Androgen receptor modulators Joshua Close 2009-01-27
7402577 Androstane 17-beta-carboxamides as androgen receptor modulators Mark E. Duggan, David B. Whitman 2008-07-22
7268153 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators Barbara Hanney, Yuntae Kim, Michael R. Krout, Robert S. Meissner, Helen J. Mitchell +2 more 2007-09-11
7109191 Benzazepinone alpha vintegrin receptor antagonists Robert S. Meissner, Paul J. Coleman, Mark E. Duggan, George D. Hartman, John Howard Hutchinson 2006-09-19
7056909 Alpha v integrin receptor antagonists 2006-06-06